Astrana Health's earnings call highlighted significant revenue and EBITDA growth, successful integration of Prospect Health, and technological advancements. However, delays in full risk contract transitions and potential Medicaid headwinds presented challenges. The positive aspects, including strong financial performance and strategic partnerships, were more prominent.

Company Guidance

During Astrana Health's Q3 2025 earnings call, guidance was updated to reflect timing adjustments regarding full-risk contracts. The company now anticipates 2025 revenue between $3.1 billion and $3.18 billion, with adjusted EBITDA projected at $200 million to $210 million. This revision is a result of several payer contracts transitioning to full-risk arrangements in Q1 2026, instead of mid-2025. Despite this delay, Astrana reported robust Q3 results, including a 100% year-over-year increase in total revenues to $956 million, driven by the integration of Prospect Health and organic growth. Adjusted EBITDA rose 52% year-over-year to $68.5 million. Medical cost trends remained within expectations, with the company achieving a stable 4.5% trend in its legacy business. Looking ahead to 2026, Astrana anticipates positive Medicare Advantage rate adjustments and synergies from the Prospect acquisition, while acknowledging potential headwinds in Medicaid and exchange markets.

Strong Revenue Growth

Astrana Health reported total revenues of $956 million for Q3 2025, up 100% year-over-year and 46% sequentially, driven by both the integration of Prospect Health and solid organic growth.

Increased Adjusted EBITDA

The company achieved adjusted EBITDA of $68.5 million, up 52% year-over-year and 42% sequentially, indicating strong profitability despite rapid scaling.

Successful Integration of Prospect Health

The acquisition of Prospect Health was completed in July, contributing positively to the company's financial performance and expanding its scale across Southern California.

AI and Technology Advancements

Astrana Health has been leveraging AI to drive efficiencies and enhance care quality, including predictive models for high-risk patients and AI-driven tools for claims analytics and clinical documentation.

Strategic Partnerships

The company expanded its partnership with Intermountain Health in Nevada and entered a new partnership with a provider group in Southern California, enhancing its market presence and service offerings.

Astrana Health (ASTH) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

ASTH Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Feb 19, 2026	2025 (Q4)	0.39 / -	-0.15	―	―	―
Nov 06, 2025	2025 (Q3)	0.47 / 0.01	0.33	-96.97% (-0.32)
Aug 07, 2025	2025 (Q2)	0.35 / 0.19	0.4	-52.50% (-0.21)
May 08, 2025	2025 (Q1)	0.21 / 0.14	0.31	-54.84% (-0.17)
Feb 27, 2025	2024 (Q4)	0.10 / -0.15	0.26	-157.69% (-0.41)
Nov 07, 2024	2024 (Q3)	0.31 / 0.33	0.47	-29.79% (-0.14)
Aug 07, 2024	2024 (Q2)	0.39 / 0.40	0.28	42.86% (+0.12)
May 07, 2024	2024 (Q1)	0.30 / 0.31	0.31	0.00% (0.00)
Feb 27, 2024	2023 (Q4)	0.15 / 0.26	-0.06	533.33% (+0.32)
Nov 07, 2023	2023 (Q3)	0.33 / 0.47	0.56	-16.07% (-0.09)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

ASTH Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Nov 06, 2025	$33.36	$25.54	-23.44%
Aug 07, 2025	$21.46	$28.08	+30.85%
May 08, 2025	$33.44	$29.71	-11.15%
Feb 27, 2025	$34.68	$25.38	-26.82%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Astrana Health Inc. (ASTH) report earnings?

Astrana Health Inc. (ASTH) is schdueled to report earning on Feb 19, 2026, TBA (Confirmed).

What is Astrana Health Inc. (ASTH) earnings time?

Astrana Health Inc. (ASTH) earnings time is at Feb 19, 2026, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is ASTH EPS forecast?

ASTH EPS forecast for the fiscal quarter 2025 (Q4) is 0.39.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing